Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry.
Cohen O, Körner A, Chlup R, Zoupas CS, Ragozin AK, Wudi K, Bartaskova D, Pappas A, Niederland T, Taybani Z, Barák L, Vazeou A; Central and Eastern Europe, Greece, and Israel Continuous Glucose Sensing Collaborative Study Group. Cohen O, et al. J Diabetes Sci Technol. 2009 Jul 1;3(4):804-11. doi: 10.1177/193229680900300429. J Diabetes Sci Technol. 2009. PMID: 20144331 Free PMC article.
Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.
Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O; Interpret Study Group. Nørgaard K, et al. Among authors: cohen o. Diabetes Technol Ther. 2013 Apr;15(4):273-80. doi: 10.1089/dia.2012.0288. Epub 2013 Feb 25. Diabetes Technol Ther. 2013. PMID: 23438304 Free PMC article.
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group. Aronson R, et al. Among authors: cohen o. Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363. Epub 2014 Apr 15. Diabetes Technol Ther. 2014. PMID: 24735134 Clinical Trial.
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I, Castaneda J, Petrovski G, Guerci B, Racault AS, Reznik Y, Cohen O, Runzis S, de Portu S, Aronson R; OpT2mise Study Group. Conget I, et al. Among authors: cohen o. Diabetes Technol Ther. 2016 Jan;18(1):22-8. doi: 10.1089/dia.2015.0159. Epub 2015 Aug 4. Diabetes Technol Ther. 2016. PMID: 26241790 Free PMC article. Clinical Trial.
Response to Letter to the Editor Regarding OpT2mise Study.
Conget I, Aronson R, Cohen O, Reznik Y. Conget I, et al. Among authors: cohen o. Diabetes Technol Ther. 2016 Jul;18(7):448. doi: 10.1089/dia.2016.0081. Epub 2016 Apr 4. Diabetes Technol Ther. 2016. PMID: 27043892 No abstract available.
1,109 results